Siemens Healthineers SHL.DE
Siemens Healthineers is a German company that designs and manufactures medical diagnostic equipment (imaging, laboratory) and offers digital health services, selling to hospitals and health centers worldwide. Siemens Healthineers has acceptable financial health (5.5) with notable earnings growth (22.4%), although revenue growth is weak (1.8%) and momentum is negative (2.85). Valuation is reasonable (P/E 19.85) and the dividend is moderate (2.27%).
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Siemens Healthineers is a German company that designs and manufactures medical diagnostic equipment (imaging, laboratory) and offers digital health services, selling to hospitals and health centers worldwide. Siemens Healthineers has acceptable financial health (5.5) with notable earnings growth (22.4%), although revenue growth is weak (1.8%) and momentum is negative (2.85). Valuation is reasonable (P/E 19.85) and the dividend is moderate (2.27%).
Score by category
| Category | Score |
|---|---|
| Financial health | 5.5 |
| Quality / Moat | 5.7 |
| Valuation | 5.8 |
| Growth | 6.2 |
| Dividend | 7.0 |
| Momentum | 2.9 |
| Risk & Context | 7.3 |
OVERALL SCORE: 5.9/10
Context and risks
The macro context (ECB rate hikes, tech sell-off) does not materially affect Siemens Healthineers. Its healthcare business is defensive and has no direct exposure to commodities or the mentioned geopolitical tension.
News considered in the analysis
- D-Wave Quantum vs. QuantumScape: Which Moonshot Tech Stock Is a Better Buy in 2026? — Listículo genérico de 'cual es mejor compra' que no aporta información específica sobre Siemens Healthineers.
- What Does Siemens Healthineers (XTRA:SHL) New Liver Disease Collaboration Mean? — Colaboración en enfermedad hepática que podría abrir una nueva oportunidad de mercado, pero el impacto financiero es incierto y probablemente moderado a corto plazo.
- Philips details $33.7M push to develop a stroke robot — Noticia sobre un competidor (Philips) que no afecta directamente a los fundamentales de Siemens Healthineers.
- Siemens Healthineers names new head of the Americas — Cambio de directivo en una región clave. Impacto moderado y positivo si la nueva gestión impulsa el crecimiento, pero el efecto es incierto y ya está parcialmente descontado.
- Is Siemens Healthineers (XTRA:SHL) Undervalued Following Its Earnings And Guidance Update? — Artículo de análisis genérico sobre valoración sin información nueva o concreta que no esté ya reflejada en el precio.
Verdict: Hold; the company has a stable business but lacks clear short-term catalysts.
Main risk: The main risk is the high net debt/EBITDA of 3.14, which could limit financial flexibility if interest rates remain high for longer than expected.
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →